Clinical Trials Browser

Gastritis, Atrophic, Gastrointestinal Neoplasms, Influenza, Human, Liver Cirrhosis, Liver Neoplasms, Pancreatic Neoplasms, Peptic Ulcer, Stomach Neoplasms, Tuberculosis, Colorectal Neoplasms, Inflammatory Bowel Diseases, Pancreatitis, Chronic

NCT03577808 2018-08-20

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

Unknown

80 enrolled

Gastrointestinal

Rectal Neoplasms

NCT02480933 2017-11-28

SISYPHUS

Phase NA Unknown

768 enrolled

Breast

Breast Neoplasms, Male

NCT02625337 2017-09-15

IMPemBra

Phase 2 Unknown

32 enrolled

Dermatologic

Melanoma

NCT03174054 2017-06-02

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

Unknown

70 enrolled

Genitourinary

Prostatic Neoplasms

NCT02938728 2016-10-25

PREDIMEL

Unknown

120 enrolled

Dermatologic

Melanoma

NCT02931981 2016-10-13

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

Unknown

50 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02898857 2016-09-13

NOTCH

Unknown

18 enrolled

Thoracic

Adenocarcinoma of Lung

NCT02406924 2015-04-02

PaMP

Phase NA Unknown

24 enrolled

Genitourinary

Prostatic Intraepithelial Neoplasia

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Phase NA Unknown

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00553124 2014-01-10

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Phase 3 Unknown

3,400 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00005071 2013-11-06

Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer

Phase NA Unknown

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00047268 2013-09-17

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

Phase 3 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00566800 2013-09-17

Erlotinib in Treating Patients With Barrett Esophagus

Phase 1 Unknown

25 enrolled

GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00669812 2013-08-26

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

Phase 2 Unknown

60 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00503958 2013-05-15

Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer

Unknown

8,300 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT01512212 2012-01-19

fnab

Phase NA Unknown

40 enrolled

Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT01442506 2011-09-28

Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus

Unknown

100 enrolled

Gastrointestinal

Barrett Esophagus

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

Phase 2 Unknown

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Clinical Trials

BIOPROSTABORD

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma

OpACIN-neo

OSIRIS

Fusobacterium Nucleatum at Colorectal Cancer Sites

PIONeeR

Melamoma4p

Bitter Taste Receptors in Oropharynx Cancer

Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

HERdi PREDICT

ProstaPilot

Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression

Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm

MYOSARC

Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue

PROMPT

IMPACNEO

PERMED01

OPT-1

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

MAPPYACTS

Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

SKINTARGET

TCR

Volatolome

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

SISYPHUS

IMPemBra

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

PREDIMEL

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

NOTCH

PaMP

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

Erlotinib in Treating Patients With Barrett Esophagus

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer

fnab

Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery